Specific Versaflex OM grades have been specially formulated to bond to PC, ABS, nylon 6/6, PC/ABS, and PPO. The Versollan™ OM series are TPU alloys specifically designed for thin-wall overmolding (both insert and two-shot molding) onto PC, ABS, and PC/ABS substrates. If the mold setting is from a previously successful part, check the original setup conditions.

Requirements: Excellent clarity, scratch resistance and exceptional toughness for visualization of medicant levels Avient Distribution HC Portfolio: Acrylic, copolyester, PC 2. Requirements: Excellent clarity, scratch resistance and exceptional toughness Avient Distribution HC Portfolio: Acrylic, copolyester, PC, clarified PP Visual Identification Use colors and additives to differentiate and identify your brand, product or batch. Requirements: Light diffusing optical properties Avient Distribution HC Portfolio: Light diffusing acrylics, PC 16.

Versaflex™ OM3060 PP包覆成型 硬度 法规 灭菌 特性 28A 环氧乙烷 柔软的半透明材料，粘性好 43A 环氧乙烷 高度可着色的解决方案， 粘性好，不易压缩变形 42A/ 50A 环氧乙烷 透明的耐高温级材料； ABS、PC可粘合 60A 环氧乙烷/蒸汽 弹性高，不易压缩变形 20A-90A 环氧乙烷 用途广泛，无填充 ABS，PC包覆成型 硬度 法规 灭菌 特性 40A USP VI级，ISO 10993 环氧乙烷 半透明 60A USP VI级，ISO 10993 环氧乙烷 透明 VERSAFLEX™ CL与DYNAFLEX™ 包覆成型，符合人体 工程学设计 触感柔软，有利于形成良好的表面 有多种颜色效果和纹理可供选择 提高抓握力、缓冲力和舒适度 提高性能表现，如密封性能、减震、隔氧、 耐刮擦和耐磨性能 降低装配成本，加工性能良好 可牢固包覆于各种基材上 血糖仪 医用工具包覆成型 注射笔 分析仪器 Dynaflex™ G2706 Dynaflex™ G2711 Versaflex™ CL2242 & CL2250 Versaflex™ G2705 N Versaflex™ HC3810 Versaflex™ OM1040 US食品接触 USP VI级，ISO 10993 材料描述 硬度 法规 灭菌 特性 45A USP VI级 55A USP VI级 70A USP VI级 43A 环氧乙烷 34A USP VI级， ISO 10993-4/5 FDA，USP VI级， ISO 10993 57A 挤出级，耐高温 再密封，压缩变形性能提高 摩擦低 Versalloy™ HC 9210-55N Versalloy™ HC 9210-70N Versalloy™ HC 9220-43N Versaflex™ HC 2110-35N Versaflex™ HC 2110-57B FDA，USP VI级， ISO 10993 环氧乙烷 加工性能良好，表面光洁、美观 环氧乙烷 环氧乙烷 加工性能良好，表面光洁、美观 加工性能良好，表面光洁、美观 高压灭菌、环氧乙烷、 高压灭菌、环氧乙烷、 VERSALLOY™ HC与VERSAFLEX™ HC 密封和再密封 柔软的橡胶质感 无抽芯，静态推塞被刺穿后再密封性良好 满足动态密封的低摩擦系数要求 可萃取物含量低 适合在聚烯烃上包覆成型 密封和密封隔膜 密封件和卫生垫圈 注射器推塞和塞头 Versalloy™ HC 9210-45N 材料描述 硬度 法规 灭菌 特性 65A/ 75A/ 84A 54A 67A 高压灭菌器 透明度高，不含增塑剂，无油 工作温度高，可高温灭菌 环氧乙烷、辐射灭菌 Versaflex™ HC MT555 Versaflex™ HC BT218 VERSAFLEX™ CL与DYNAFLEX™ 高透明度级，不含增塑剂 无色透明级，配方不含邻苯二甲酸酯增塑剂 符合医疗法规USP VI级和ISO 10993-4、5的 要求 食品接触用并符合FDA标准 可高压灭菌和辐射灭菌 可萃取物含量低 透明度高（雾度50 4.1, 100 4.5, 100 4, 70 6, 70 拉伸模量（MPa） 2200 2700 2600 2350 1820 1820 挠曲强度（MPa） 80 90 104 86 68 68 挠曲模量（MPa） 2500 2700 2500 2300 1980 1590 HDT：0.45、1.8（MPa） 110, 80 90, 80 100, 89 123, 100 123, 64 100, 70 UL-94等级，3.0mm 5VA V-0 5VA V-0 HB V-0 UL-94等级，1.5mm V-0 V-0 5VB V-0 HB V-0 UL-94等级，0.75mm V-1 V-2 V-0 无 无 V-2 竞争材料对比 医疗保健特种工程聚合物配方 TRILLIANT™ HC热塑性塑料 Trilliant™ HC高性能热塑性弹性体系列配方是专为应对日趋严苛的医疗器械和设备而开发的。 TRILLIANT™ HC8920 TRILLIANT™ HC2020 Trilliant™ HC2020 材料描述 基料 共聚酯 Trilliant™ HC8910/8920 聚酮/ABS共混物 Trilliant™ HC2120 Tritan Trilliant™ HC3120 PC Trilliant™ HC5210 PP Trilliant™ HC6010 PA6 Trilliant™ HC6610 PA66 Trilliant™ GRV-NP-110-W PA12 TRILLIANT™ HC热塑性塑料 作为FR PC/ABS、FR PC/PET和FR COPE的 耐化学性替代品，在各种颜色的应用中，其 阻燃等级在1.5mm和0.75mm厚度下分别可 达到UL 94黄卡V-0级和V-1级。 在对普通消毒剂的耐受性方面优于PC/ABS、 PC/PET和COPE 暴露在普通医院消毒剂下72小时后仍能保持 抗拉强度，相较于PC混合物和COPE，具有 更出色的长期耐化学性 具有良好的抗冲击性和耐热性 有自然色等级、标准医用颜色或定制预着色 产品可供选择 医疗设备外壳 核磁共振成像、X射线、CT扫描仪部件 手术器械，如吻合器、解剖器、剪刀等 自动注射笔 测试项 比重 熔体流动指数 （230OC， 2.16KG） 抗拉强度 挠曲强度 挠曲模量 冲击强度 缺口，IZOD 测试项 方法 ASTM D-792 ASTM D-1238 ASTM D-638 ASTM D-790 ASTM D-790 ASTM D-256 ASTM D-257 单位 -- g/10min MPa MPa MPa J/m Ohms/sq.

Picture of plaques originally made from preforms containing Fortis Amber-1 and Amosorb Solo2-2. After having the flakes coming from the original bottles go through up to 5 melt histories, it was shown that the L*, a* and b* values underwent minimal changes, thus allowing for retention of the original desired tone of the bottles. This could represent an opportunity for the value chain looking into introducing bottles-to-bottles back to their original standard.

Base Resin PC PC/PSU PES PEI PP ABS PEEK PA Barrel Temperatures* °F (°C) Rear Zone 530–560 (277–293) 550–575 (288–302) 660–700 (349–371) 675–725 (357–385) 390–420 (199–216) 425–460 (219–238) 680–730 (360–388) 430–500 (221–260) Center Zone 515–560 (269–288) 540–565 (282–296) 650–690 655–710 (352–377) 380–405 (193–207) 415–450 (213–232) 670–710 (354–377) 420–490 (216–254) Front Zone 510–525 (266–274) 530–555 (277–291) 640–680 (338–360) 655–700 (346–371) 370–395 (188–202) 405–440 (207–227) 410–480 (210–249) Nozzle 520–535 (271–280) 540–565 (282–296) 650–690 665–710 (352–377) 380–400 (193–204) 415–450 (213–232) 660–700 (349–371) 420–490 (216–254) Melt Temperature 525–560 (274–293) 530–580 (277–304) 650–700 (343–371) 660–730 (349–388) 375–395 (191–202) 410–460 (210–238) 650–730 (343–388) 420–500 (216–260) Mold Temperature 175–250 (80–121) 160–220 (71–104) 280–350 (138–177) 275–350 (135–177) 100–135 (38–57) 150–180 (66–82) 300–425 (149–219) 160–230 (71–110) Pack & Hold Pressure 50%–75% of Injection Pressure Injection Velocity in/s 0.5–2.0 Back Pressure psi 50 Screw Speed rpm 40–70 40–70 40–70 40–70 40–70 40–70 40–70 40–70** Drying Parameters °F (°C) 6 hrs @ 250 4 hrs @ 250 4 hrs @ 275 (135) 4 hrs @ 250 3 hrs @ 300 (150) 2 hrs @ 200 (93) 3 hrs @ 275 (135) 4 hrs @ 180 (82) Cushion in 0.125–0.250 Screw Compression Ratio 2.0:1–2.5:1 2.0:1–2.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 Nozzle Type General General General General General General General Reverse Taper Clamp Pressure 5–6 Tons/in2 * A reverse temperature profile is important to obtain optimum conductive properties. Cut vent depths to: - PC Compounds: 0.001"–0.002" depth and 0.250" width - PC/PSU Compounds: 0.002"–0.003" depth and 0.250" width - PES Compounds: 0.003"–0.004" depth and 0.250" width - PEI Compounds: 0.001"–0.003" depth and 0.250" width - PP Compounds: 0.001"–0.002" depth and 0.250" width - ABS Compounds: 0.0015"–0.0025" depth and 0.250" width - PEEK Compounds: 0.002"–0.004" depth and 0.250" width - Nylon Compounds: 0.002" min. depth and 0.250" width • Increase vent depth to 0.040" (1.0mm) at 0.250" (4.0mm) away from the cavity and vent to atmosphere.

These include PE, PP, ABS, SAN, PC/ABS, PC, PA6, 66 and 12, cyclic olefins (COP), high performance polymers, and elastomers such as EVA, SEBS, TPU and PEBA. ADDING VALUE TO A WIDE RANGE OF HEALTHCARE APPLICATIONS PROVIDING STANDARD AND CUSTOM COLORANTS & ADDITIVES STANDARD COLOR RANGES To speed up time to market, Avient offers a standard range of colorants using pre-tested raw materials suitable for a wide range of polymers including PE, PP, PEBA, PC, and others. APPLICATION PORTFOLIO DESCRIPTION General use Opaque and transparent colors in PP, PE, COC, ABS, POM, PC, TPU, PEEK, and more Needle hubs and cannulae Opaque and translucent colors evaluated to ISO 6009 Ophthalmic caps and closures 13 standard colors in PE matched to American Academy of Ophthalmology; biologically evaluated to USP standard White pharmaceutical packaging White colorants for PE, HDPE, PP covering solid dose to nasal packaging needs Amber pharmaceutical packaging Pre-tested amber colorants LSR silicones For LSR silicones and transparent color PET/PP (e.g. amber) FUNCTIONALITY ADDITIVE PERFORMANCE UV protection in transparent packaging Blocks UV in 290–450nm for PP, PE, PETG, COP Processing aid/friction reduction Optimizes processing for PE, PP, ABS, POM—non-migrating Nucleation for reduced material consumption/cycle time Improves thermal and mechanical properties of PE and PP and allows wall thinning to support sustainability Clarifying Improves clarity of transparent PP applications with reduced migration and improved thermal stability—sorbitol-free Laser marking/welding Activates the polymer to absorb Nd-YAG laser for fast reliable marking/assembly Gamma/e-beam sterilization Preserves the properties of PP and COP, reduces yellowing and compensates for discoloration Anti-static Reduces static buildup in applications such as films in API handling and inhaler spacers/nebulizers Antioxidant Provides thermal protection during converting/ downstream sterilization Anti-counterfeit/brand protection Covert and non-covert systems SUPPORTING SUSTAINABILITY TARGETS As the need to integrate sustainability in the design of healthcare products is growing, manufacturers of medical devices, diagnostic products and pharmaceutical packaging are looking for materials with a more environmentally friendly profile.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; disruptions or inefficiencies in our supply chain, logistics, or operations; changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change; fluctuations in raw material prices, quality and supply, and in energy prices and supply; demand for our products and services; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; our ability to achieve strategic objectives and successfully integrate acquisitions, including the implementation of a cloud-based enterprise resource planning system, S/4HANA; other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts, and any recessionary conditions; and other factors described in our Annual Report on Form 10-K for the year ended View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-announces-pricing-of-650-million-6-250-senior-notes-due-2031--302240004.html

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows including without any limitation, any supply chain and logistics issues; the speed and strength of growth in the global 5G infrastructure market; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; our ability to consummate and successfully integrate acquisitions; and amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions. View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-expects-double-digit-sales-growth-in-5g-applications-301375646.html

This webcast replaces the previously communicated earnings webcast date that was originally scheduled to be held on View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-announces-agreement-to-acquire-dsm-protective-materials-dyneema-and-plans-to-explore-sale-of-distribution-301528666.html

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: changes in the economy in India; our ability to realize anticipated savings and operational benefits from the realignment of assets, including the planned closure of certain manufacturing facilities; the timing of closings and shifts of production to new facilities related to asset realignments and any unforeseen disruptions of service or quality caused by such closings and/or production shifts; separation and severance amounts that differ from original estimates, amounts for non-cash charges related to asset write-offs and accelerated depreciation realignments of property, plant and equipment, that differ from original estimates; our ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired companies into our operations, retain the management teams of acquired companies and retain relationships with customers of acquired companies including without limitation Spartech Corporation; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.